Ginkgo Bioworks Holdings (DNA) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Ginkgo Bioworks Holdings (DNA) is Moderate Underperform.

The composite score behind that read is -0.27, weighing +0.32 of bullish evidence against -0.36 bearish.

Ginkgo Bioworks Holdings last closed at $14.98, +21.30% on the session.

Against the IVW growth benchmark the position is +20.38% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

16 graded predictions for DNA so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Ginkgo Bioworks Holdings in the 16th percentile on return on equity, where 100 is best.

Ginkgo Bioworks Holdings is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $794.60M.

StockMap tracks Ginkgo Bioworks Holdings as the 29th largest of the 39 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 34 Neutral, 4 Moderate Underperform and 1 Strong Underperform.

On that composite Ginkgo Bioworks Holdings ranks 36th of 39 in the group, against a group median of -0.08.